---
title: "Critical Vulnerability in Eppendorf BioFlo 320 Bioreactors Exposes Full System Access"
short_title: "Eppendorf BioFlo 320 critical flaw exposes bioreactors"
description: "A hard-coded password vulnerability (CVE-2026-7251) in Eppendorf BioFlo 320 bioreactors allows attackers full control. Learn mitigation steps and risks."
author: "Vitus"
date: 2024-10-02
categories: [Cybersecurity, Vulnerabilities]
tags: [bioreactor security, cve-2026-7251, hard-coded password, healthcare cybersecurity, ics security]
score: 0.85
cve_ids: [CVE-2026-7251]
---
## TL;DR
A critical vulnerability (CVE-2026-7251) in Eppendorf BioFlo 320 bioreactors enables attackers to gain full access to system functionality and data by exploiting a hard-coded password in the VNC server. The flaw, rated 9.8 (CRITICAL), affects all versions of the device and could disrupt healthcare and public health operations worldwide. Eppendorf has released a software update to remove VNC access—users must apply it immediately.
Main Content
### Introduction
The Eppendorf BioFlo 320 bioreactor, a cornerstone in healthcare and public health laboratories, has been found to contain a severe security flaw that could allow unauthorized access to critical systems. The vulnerability, tracked as CVE-2026-7251, involves a hard-coded password in the device’s VNC server, enabling attackers to take full control of the bioreactor’s interface if remote access is enabled. With a CVSS score of 9.8, this flaw poses a significant risk to global healthcare infrastructure.
### Key Points
- Critical Vulnerability: CVE-2026-7251 allows attackers to exploit a hard-coded password in the VNC server of Eppendorf BioFlo 320 bioreactors.
- Global Impact: Affects healthcare and public health sectors worldwide, with devices deployed in laboratories across multiple countries.
- Full System Access: Successful exploitation grants attackers unrestricted control over the bioreactor’s functionality and data.
- No Encryption: VNC traffic is unencrypted, increasing the risk of interception and manipulation.
- Mitigation Available: Eppendorf has released a software update to remove VNC access and recommends immediate action.
### Technical Details
The vulnerability stems from the use of a hard-coded password in the VNC server of the Eppendorf BioFlo 320 bioreactor. If an attacker knows the network address of a device with remote access enabled, they can bypass authentication and gain full control of the user interface. This access includes:
- Control panel features: Manipulation of bioreactor settings and operations.
- Data access: Unauthorized viewing or extraction of sensitive experimental or patient-related data.
- Unencrypted traffic: VNC communications are not encrypted, exposing them to interception or tampering.
The flaw affects all versions of the BioFlo 320 bioreactor and is classified under CWE-259 (Use of Hard-coded Password).
### Impact Assessment
#### Sectors at Risk
- Healthcare and Public Health: Bioreactors are critical for research, drug development, and clinical applications. Compromised devices could disrupt operations, leading to delays in medical advancements or patient care.
- Global Reach: Deployed worldwide, the vulnerability exposes laboratories in Germany, the U.S., and other countries to potential attacks.
#### Potential Consequences
- Operational Disruption: Attackers could alter bioreactor settings, leading to failed experiments or contaminated samples.
- Data Breaches: Sensitive research data or patient information could be stolen or manipulated.
- Regulatory Violations: Unauthorized access may violate compliance standards like HIPAA or GDPR, resulting in legal penalties.
### Attack Vector
The vulnerability can be exploited remotely if:
1. The VNC server is enabled on the BioFlo 320 bioreactor.
2. The attacker knows the network address of the device.
3. The hard-coded password is used to bypass authentication.
While VNC is disabled by default, it can be enabled locally, and older documentation may still reference its configuration.
### Mitigation Steps
Eppendorf has released a software update (Version 5.0) to address the vulnerability. Users are urged to:
1. Apply the Update: Download and install the latest software from Eppendorf’s official website.
2. Disable VNC: Verify that VNC is disabled on all BioFlo 320 devices.
3. Restrict Access: Limit VNC configuration changes to Admin and Supervisor roles only.
4. Network Security: Isolate bioreactors from business networks and use firewalls to minimize exposure.
5. Secure Remote Access: If remote access is required, use VPNs with up-to-date security protocols.
### Affected Systems
- Product: Eppendorf BioFlo 320 Bioreactor
- Vendor: Eppendorf (Headquarters: Germany)
- Versions: All versions (vers:all/*)
- Status: Known to be affected
## Conclusion
The CVE-2026-7251 vulnerability in Eppendorf BioFlo 320 bioreactors highlights the critical risks posed by hard-coded credentials in medical and laboratory devices. With a CVSS score of 9.8, this flaw demands immediate action from healthcare organizations to apply patches, disable vulnerable features, and secure their networks. Failure to act could result in operational disruptions, data breaches, and regulatory consequences.
For more details, refer to the CISA advisory and Eppendorf’s software updates.
## References
[^1]: CISA. "ICS Medical Advisory (ICSMA-26-146-01)". Retrieved 2024-10-02.
[^2]: Eppendorf. "Software Downloads". Retrieved 2024-10-02.
[^3]: MITRE. "CWE-259: Use of Hard-coded Password". Retrieved 2024-10-02.